⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 25, 2024European Journal of Ophthalmology

Ruthenium-106 (¹⁰⁶Ru) plaque brachytherapy for treatment of circumscribed choroidal hemangioma

Vidhi Bajpai Vishal Raval Vijay Anand Reddy P Swathi Kaliki

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bajpai et al. (2024) studied this question.

synapsesocial.com/papers/68e686bfb6db64358760f32d https://doi.org/10.1177/11206721241257974

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Ultrasound guided Ru106 plaque brachytherapy for treatment of exudative retinal detachment in children with diffuse choroidal haemangioma2024
2Choroidal Melanoma Treated With Ruthenium‐106 Eye Plaque Brachytherapy: Results of an Australian Statewide Service From November 2020 to January 2025Review · 2026
3Local tumour control and patient survival after ruthenium-106 brachytherapy for small choroidal melanoma2024 · 8 citations
4Tumor- and Radiation-Related Complications after Ruthenium-106 Brachytherapy in Small to Medium Uveal Melanomas (Part 1)2024 · 6 citations
5Use of iodine-125 episcleral brachytherapy treatment for circumscribed choroidal hemangioma in a pediatric patient2024

More related papers

Combined Local Excision and Brachytherapy with Ruthenium-106 in the Treatment of Epibulbar Malignancies2010
Treatment-Related Complications and Functional Results after Ruthenium-106 Brachytherapy in Small to Medium Size Uveal Melanomas (Part 2)2024
Stereotactic radiosurgery in symptomatic circumscribed choroidal hemangiomas2026

More from European Journal of Ophthalmology

Apoptotic, oxidative stress, and endothelial signaling protein expression in lens epithelial cells of patients with pseudoexfoliation syndromeWed,
Visual and anatomical outcomes of early versus delayed anti-VEGF switching after bevacizumab loading in diabetic macular oedemaMon,